GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biostax BTAX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biostax — daily BTAX Delayed
Market value
$15,742
Last close × shares
Volume
2.2k
Shares, 30 Oct 2026

About Biostax

Its shares trade under the ticker BTAX. It has been listed since 16 July 2001. In the fiscal year to 31 December 2018, it reported revenue of $113,500 and a net loss of $8.2m. At that date it held total assets of $91,600 and shareholders' equity of −$11.3m.

Immune Therapeutics, Inc. engages in the development and marketing of pharmaceutical, biotechnology, and MedTech products. The company is headquartered in Winter Park, Florida. The company went IPO on 2001-07-16. Biostax has partnerships in the fields of autoimmunity and immune restoration, which focuses on delivering solutions for people living with autoimmunity, chronic inflammation, infection, and cancer. Its subsidiary BiostaxRx, is focused on the treatment of inflammaging disease. Its product portfolio includes Londonal, JKB-122 and Low Dose Naltrexone. Lodonal is a once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). JKB-122 is a therapy developed for the purposes of treating Autoimmune Hepatitis (AIH), Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) that shows anti-fibrotic, immune modulating, and/or anti-inflammatory effects.

Figures and description from our data supplier, not checked against the company's own report.

More about Biostax →

Latest on Biostax

Our reporting

We have not reported on Biostax yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biostax's ticker?

Biostax trades as BTAX on its US listing, under ISIN US45252A3059.

What was Biostax's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.